 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Veracyte, Inc. Nasdaq: VCYT the Company today announced that it has commenced an underwritten public offering of 400.0 million in shares of its common stock. All of the shares are being offered by Veracyte. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional 60.0 million in shares of its common stock at the public offering price, less underwriting discounts and commissions. Veracyte inte 